Published in Cancer Weekly, February 10th, 1997
Despite numerous reports of clinical trials demonstrating decreased breast cancer mortality for women aged 40-49 through mammographic screening, said the ACS, the conference Panel concluded "that the available data do not warrant a single recommendation for mammography for all women in their forties."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.